W.G. Shaheen & Associates Dba Whitney & CO Bridge Bio Pharma, Inc. Call Options Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$894 Million
Q1 2025

Call Options

1 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2025 May 06, 2025	BUY	$28.12 - $37.59 $337,440 - $451,080	12,000 New	12,000 $414,000

Others Institutions Holding BBIO

# of Institutions

362

Shares Held

185M

Call Options Held

12.8M

Put Options Held

2.09M

Viking Global Investors LP

22.1M
Shares

$846 Million
2.55% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

19.3M
Shares

$738 Million
30.7% of portfolio
Vanguard Group Inc Valley Forge, PA

14.9M
Shares

$571 Million
0.01% of portfolio
Black Rock Inc. New York, NY

12.4M
Shares

$477 Million
0.01% of portfolio
Janus Henderson Group PLC London, X0

7.17M
Shares

$275 Million
0.14% of portfolio

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.68B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account